Scientific Sessions

Pediatric oncology and hematology focus on the diagnosis, treatment, and management of cancers and blood disorders in children. Childhood cancers, such as leukemia, lymphoma, and solid tumors, differ significantly from adult malignancies in their biology, progression, and response to therapy. Advances in molecular genetics, immunotherapy, and targeted treatments have dramatically improved survival rates and outcomes for pediatric patients. Innovations such as CAR-T cell therapy, precision chemotherapy, and minimally invasive surgical techniques allow clinicians to tailor treatments to each child’s specific condition, reducing side effects and enhancing long-term recovery. Early detection and risk stratification, supported by advanced imaging and genetic profiling, have become critical tools in optimizing therapeutic strategies.

Hematologic disorders, including anemia, hemophilia, thalassemia, and sickle cell disease, remain a major area of pediatric concern. Advances in blood transfusion protocols, iron chelation therapy, and gene therapy are transforming disease management and improving quality of life. Multidisciplinary care teams, involving oncologists, hematologists, nurses, and psychosocial support specialists, provide holistic treatment that addresses both medical and emotional needs. Pediatric oncology and hematology also emphasize supportive care, including infection prevention, pain management, and rehabilitation, to ensure children can maintain normal development and education during treatment. With ongoing research and the integration of novel therapies, this field continues to evolve, offering hope for better survival, reduced treatment complications, and healthier futures for children facing life-threatening illnesses.